Rekindle Therapeutics Inc.

Biotechnology company · Cambridge, Massachusetts, United States

Rekindle Therapeutics Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $1.1 million sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Rekindle Therapeutics at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Earliest incorporation on record2018

SEC CIK1757971

What does Rekindle Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $1.1 million sold (2018).

Frequently asked questions about Rekindle Therapeutics

Where is Rekindle Therapeutics headquartered?

Rekindle Therapeutics Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Rekindle Therapeutics do?

Rekindle Therapeutics Inc. is a biotechnology company.

When was Rekindle Therapeutics founded?

The earliest incorporation on record for Rekindle Therapeutics Inc. is in 2018, according to public company registers.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences